intracameral mydriatic
Showing 1 - 25 of 73
Corneal Endothelial Cell Loss, Mydriasis, Cataract Trial in Cairo (Fydrane®: (Manufacturer DELPHARM TOURS, FRANCE).)
Completed
- Corneal Endothelial Cell Loss
- +2 more
- Fydrane®: (Manufacturer DELPHARM TOURS, FRANCE).
-
Cairo, EgyptCairo University - Kasr Alainy hospital
May 19, 2020
Cataract Surgery Trial in Roma (Efficacy of a Standardized Intracameral Combination of Mydriatics and Anesthetic (Mydrane ®) for
Completed
- Cataract Surgery
- Efficacy of a Standardized Intracameral Combination of Mydriatics and Anesthetic (Mydrane ®) for Cataract Surgery in Patients With Concomitant Primary Open Angle Glaucoma
-
Roma, ItalyPoliclinico Gemelli
Jul 4, 2023
Endophthalmitis Trial in Saint George (Moxifloxacin, Placebo)
Not yet recruiting
- Endophthalmitis
- Moxifloxacin
- Placebo
-
Saint George, UtahZion Eye Institute
Dec 31, 2022
Mydriatic Eye Drops in Retinopathy of Prematurity Examinations
Completed
- Retinopathy of Prematurity
- +3 more
- NIRS(INVOS 5100; Covidien Somanetics, Troy, MI
-
Istanbul, TurkeyIstanbulTRH
May 19, 2023
Posterior Synechiae of Iris Trial in Petah Tikva (Cyclopentolate Hydrochloride 1.0% eye drops)
Completed
- Posterior Synechiae of Iris
- Cyclopentolate Hydrochloride 1.0% eye drops
-
Petah Tikva, IsraelRabin Medical Center
Nov 5, 2022
Cataract, Endothelial Cell Loss, Corneal Trial in Mexico City (EO2002, Sham injection)
Recruiting
- Cataract
- Endothelial Cell Loss, Corneal
- EO2002
- Sham injection
-
Mexico City, Cdmx, MexicoAsociacion para Evitar la Ceguera en Mexico
Dec 1, 2022
Corneal Edema, Corneal Endothelial Dystrophy, Endothelial Dysfunction Trial in Mexico City (EO2002, Ripasudil)
Recruiting
- Corneal Edema
- +7 more
- EO2002
- Ripasudil
-
Mexico City, Cdmx, MexicoAsociacion para Evitar la Ceguera en Mexico
Dec 1, 2022
Retinal Fundus Camera Evaluation
Completed
- Normal Healthy Subjects With no Known Ocular Diseases
- Topcon TRC-NW400
- +4 more
-
Oakland, New JerseyTopcon Medical Systems, Inc.
Jun 6, 2022
NW500 Non-Mydriatic Retinal Camera Clinical Performance Study
Completed
- Fundus Photography
- fundus photography
-
Oakland, New JerseyTopcon Healthcare Solutions
Jun 6, 2022
Corneal Edema Trial in Giza (Control group, Dexamethasone group, Triamcinolone (TA) group)
Completed
- Corneal Edema
- Control group
- +2 more
-
Giza, Cairo, EgyptKhaled G Abueleinen
Feb 27, 2022
Endophthalmitis, Macula Edema, Cataract Trial in Campinas (Moxifloxacin Injection)
Completed
- Endophthalmitis
- +2 more
- Moxifloxacin Injection
-
Campinas, São Paulo, BrazilHospital das Clínicas da UNICAMP
Nov 2, 2022
Pain Reduction Trial (1% preservative-free lidocaine, Phenylephrine 1.0%/ Ketorolac 0.3%)
Withdrawn
- Pain Reduction
- 1% preservative-free lidocaine
- Phenylephrine 1.0%/ Ketorolac 0.3%
- (no location specified)
Jun 9, 2022
Cataract Trial in Baltimore (Topical phenylephrine 2.5%, Topical cyclopentolate 1%, Intracameral Lidocaine 1%)
Terminated
- Cataract
- Topical phenylephrine 2.5%
- +3 more
-
Baltimore, MarylandWilmer Eye Institute, Johns Hopkins
Aug 22, 2019
Epinephrine Toxicity, Cataract, Carbachol Adverse Reaction Trial in Ordu (Intracameral administration of epinephrine and
Completed
- Epinephrine Toxicity
- +3 more
- Intracameral administration of epinephrine and carbachol during cataract surgery
-
Ordu, ABD Dışında, TurkeyOrdu University
Feb 2, 2022
Cataract Trial in Jakarta Pusat (Moxifloxacin Ophthalmic Solution, Levofloxacin Ophthalmic)
Recruiting
- Cataract
- Moxifloxacin Ophthalmic Solution
- Levofloxacin Ophthalmic
-
Jakarta Pusat, DKI Jakarta, IndonesiaFakultas Kedokteran Universitas Indonesia
Feb 23, 2023
Glaucoma, Neovascular, Vascular Endothelial Growth Factor Overexpression Trial in Hat-yai (Intracameral injection, Intravitreal
Recruiting
- Glaucoma, Neovascular
- Vascular Endothelial Growth Factor Overexpression
- Intracameral injection
- Intravitreal injection
-
Hat-yai, Songkhla, ThailandGlaucoma unit , Department of Ophthalmology Faculty of Medicine
Feb 3, 2022
Safety Study of Bimatoprost Intracameral Implant (DURYSTA)
Recruiting
- Open-angle Glaucoma
- Ocular Hypertension
-
Culver City, California
- +24 more
Feb 21, 2022
Retinopathy of Prematurity Trial in Thessaloníki (Microdrop administration [phenylephrine 1.67% + tropicamide 0.33% (drop
Completed
- Retinopathy of Prematurity
- Microdrop administration [phenylephrine 1.67% + tropicamide 0.33% (drop volume: 6-7 μL)]
- Standard drop administration [phenylephrine 1.67% + tropicamide 0.33% (drop volume: 28-34 μL)]
-
Thessaloníki, Greece"Papageorgiou" General Hospital
Mar 23, 2022
Mydriasis, Dilation Trial in United States (Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle)
Completed
- Mydriasis
- Dilation
- Phentolamine Ophthalmic Solution 0.75%
- Phentolamine Ophthalmic Solution Vehicle
-
Newport Beach, California
- +14 more
Jun 20, 2022
Contact Between OTX-TIC Intracameral Ocular Implant and Corneal
Not yet recruiting
- Corneal Endothelium
- OCT Imaging
- (no location specified)
Apr 17, 2023
Diabetic Retinopathy, Artificial Intelligence, Diabetes Trial (Analysed Retinophotography)
Not yet recruiting
- Diabetic Retinopathy
- +2 more
- Analysed Retinophotography
- (no location specified)
Jul 6, 2022
Endophthalmitis, Trauma, Corneal Trial in São Paulo (Intraocular Instillation Solution, Moxifloxacin Ophthalmic)
Recruiting
- Endophthalmitis
- Trauma, Corneal
- Intraocular Instillation Solution
- Moxifloxacin Ophthalmic
-
São Paulo, SP, BrazilDept of Ophthalmology - UNIFESP/Hospital São Paulo
Nov 3, 2021
Retinopathy of Prematurity Trial in Thessaloníki (Microdrop administration of phenylephrine 1.67% and tropicamide 0.33%,
Recruiting
- Retinopathy of Prematurity
- Microdrop administration of phenylephrine 1.67% and tropicamide 0.33%
- Standard drop administration of phenylephrine 1.67% and tropicamide 0.33%
-
Thessaloníki, GreecePapageorgiou General Hospital
Oct 14, 2021
Cataract Trial in Graz (Eye injection (Mydrane), eye drops (Phenylephrin), eye drops (Tropicamid))
Completed
- Cataract
- Eye injection (Mydrane)
- +2 more
-
Graz, AustriaMedical University Graz
Oct 11, 2021
Retinopathy of Prematurity Trial (0.5% cyclopentolate and 2.5% phenylephrine, 0.5% tropicamide + 0.5% phenylephrine, 0.5%
Completed
- Retinopathy of Prematurity
- 0.5% cyclopentolate and 2.5% phenylephrine
- +2 more
- (no location specified)
Apr 8, 2021